Literature DB >> 27064858

Vaccination against HPV-Associated Neoplasias: Recommendations from the Current S3 Guideline of the HPV Management Forum of the Paul-Ehrlich Society - AWMF Guidelines, Registry No. 082-002 (short version), valid until Dec. 31st, 2018.

G Gross1, N Becker2, N H Brockmeyer3, S Esser4, U Freitag5, M Gebhardt6, L Gissmann7, P Hillemanns8, H Grundhewer9, H Ikenberg10, H Jessen11, A Kaufmann12, S Klug13, J P Klußmann14, A Nast15, D Pathirana15, K U Petry16, H Pfister17, U Röllinghof18, P Schneede19, A Schneider20, E Selka18, S Singer21, S Smola22, B Sporbeck15, M von Knebel Doeberitz23, P Wutzler24.   

Abstract

Entities:  

Year:  2014        PMID： 27064858      PMCID： PMC4812874          DOI： 10.1055/s-0033-1360170

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN： 0016-5751            Impact factor:   2.915


× No keyword cloud information.
  45 in total

1.  HPV vaccine against anal intraepithelial neoplasia.

Authors:  Ulrike Wieland; Markus Stuecker; Alexander Kreuter
Journal:  N Engl J Med       Date:  2012-01-26       Impact factor: 91.245

Review 2.  HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review.

Authors:  E A Burger; H Kornør; M Klemp; V Lauvrak; I S Kristiansen
Journal:  Gynecol Oncol       Date:  2010-12-04       Impact factor: 5.482

3.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

Review 4.  The known unknowns of HPV natural history.

Authors:  Patti E Gravitt
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 5.  Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics.

Authors:  T C Pomfret; J M Gagnon; A T Gilchrist
Journal:  J Clin Pharm Ther       Date:  2011-02       Impact factor: 2.512

6.  [Demyelinating disease and vaccination of the human papillomavirus].

Authors:  M Josefa Álvarez-Soria; Amalia Hernández-González; Sira Carrasco-García de León; M Ángeles del Real-Francia; M José Gallardo-Alcañiz; José L López-Gómez
Journal:  Rev Neurol       Date:  2011-04-16       Impact factor: 0.870

7.  Monitoring the safety of quadrivalent human papillomavirus vaccine: findings from the Vaccine Safety Datalink.

Authors:  Julianne Gee; Allison Naleway; Irene Shui; James Baggs; Ruihua Yin; Rong Li; Martin Kulldorff; Edwin Lewis; Bruce Fireman; Matthew F Daley; Nicola P Klein; Eric S Weintraub
Journal:  Vaccine       Date:  2011-09-09       Impact factor: 3.641

8.  No confirmed case of human papillomavirus DNA-negative cervical intraepithelial neoplasia grade 3 or invasive primary cancer of the uterine cervix among 511 patients.

Authors:  Gerd Böhmer; Adriaan J C van den Brule; Oliver Brummer; ChrisJ L M Meijer; K Ulrich Petry
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

9.  Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy.

Authors:  Samar Ojaimi; Jim P Buttery; Tony M Korman
Journal:  Vaccine       Date:  2009-06-23       Impact factor: 3.641

10.  Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data.

Authors:  Elmar A Joura; Suzanne M Garland; Jorma Paavonen; Daron G Ferris; Gonzalo Perez; Kevin A Ault; Warner K Huh; Heather L Sings; Margaret K James; Richard M Haupt
Journal:  BMJ       Date:  2012-03-27
View more
  2 in total

1.  [Prophylactic vaccination against HP viruses for the prevention of cervical cancer : Implementation of gender neutral, prophylactic vaccination in Germany as an effective instrument for prevention].

Authors:  N Huck
Journal:  Urologe A       Date:  2018-07       Impact factor: 0.639

2.  Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline.

Authors:  Silvina Arrossi; Sarah Temin; Suzanne Garland; Linda O'Neal Eckert; Neerja Bhatla; Xavier Castellsagué; Sharifa Ezat Alkaff; Tamika Felder; Doudja Hammouda; Ryo Konno; Gilberto Lopes; Emmanuel Mugisha; Rául Murillo; Isabel C Scarinci; Margaret Stanley; Vivien Tsu; Cosette M Wheeler; Isaac Folorunso Adewole; Silvia de Sanjosé
Journal:  J Glob Oncol       Date:  2017-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.